Sustained NF-κB activation allows mutant alveolar stem cells to co-opt a regeneration program for tumor initiation

IF 19.8 1区 医学 Q1 CELL & TISSUE ENGINEERING
Frances J. England, Ignacio Bordeu, Minn-E. Ng, JaeHak Bang, Bumsoo Kim, Jinwook Choi, Erik C. Cardoso, Bon-Kyoung Koo, Benjamin D. Simons, Joo-Hyeon Lee
{"title":"Sustained NF-κB activation allows mutant alveolar stem cells to co-opt a regeneration program for tumor initiation","authors":"Frances J. England, Ignacio Bordeu, Minn-E. Ng, JaeHak Bang, Bumsoo Kim, Jinwook Choi, Erik C. Cardoso, Bon-Kyoung Koo, Benjamin D. Simons, Joo-Hyeon Lee","doi":"10.1016/j.stem.2025.01.011","DOIUrl":null,"url":null,"abstract":"Disruptions to regulatory signals governing stem cell fate open the pathway to tumorigenesis. To determine how these programs become destabilized, we fate-map thousands of murine wild-type and <em>KrasG12D</em>-mutant alveolar type II (AT2) stem cells <em>in vivo</em> and find evidence for two independent AT2 subpopulations marked by distinct tumorigenic capacities. By combining clonal analyses with single-cell transcriptomics, we unveil striking parallels between lung regeneration and tumorigenesis that implicate <em>Il1r1</em> as a common activator of AT2 reprogramming. We show that tumor evolution proceeds through the acquisition of lineage infidelity and reversible transitions between mutant states, which, in turn, modulate wild-type AT2 dynamics. Finally, we discover how sustained nuclear factor κB (NF-κB) activation sets tumorigenesis apart from regeneration, allowing mutant cells to subvert differentiation in favor of tumor growth.","PeriodicalId":9665,"journal":{"name":"Cell stem cell","volume":"85 1","pages":""},"PeriodicalIF":19.8000,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell stem cell","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.stem.2025.01.011","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL & TISSUE ENGINEERING","Score":null,"Total":0}
引用次数: 0

Abstract

Disruptions to regulatory signals governing stem cell fate open the pathway to tumorigenesis. To determine how these programs become destabilized, we fate-map thousands of murine wild-type and KrasG12D-mutant alveolar type II (AT2) stem cells in vivo and find evidence for two independent AT2 subpopulations marked by distinct tumorigenic capacities. By combining clonal analyses with single-cell transcriptomics, we unveil striking parallels between lung regeneration and tumorigenesis that implicate Il1r1 as a common activator of AT2 reprogramming. We show that tumor evolution proceeds through the acquisition of lineage infidelity and reversible transitions between mutant states, which, in turn, modulate wild-type AT2 dynamics. Finally, we discover how sustained nuclear factor κB (NF-κB) activation sets tumorigenesis apart from regeneration, allowing mutant cells to subvert differentiation in favor of tumor growth.

Abstract Image

持续的NF-κB激活允许突变的肺泡干细胞参与肿瘤起始的再生程序
对控制干细胞命运的调节信号的破坏打开了肿瘤发生的途径。为了确定这些程序是如何变得不稳定的,我们在体内绘制了数千个小鼠野生型和krasg12d突变型肺泡II型(AT2)干细胞的命运图,并找到了两个独立的AT2亚群的证据,这些亚群具有不同的致瘤能力。通过结合克隆分析和单细胞转录组学,我们揭示了肺再生和肿瘤发生之间惊人的相似之处,暗示Il1r1是AT2重编程的共同激活因子。我们发现肿瘤的进化是通过获得谱系不忠和突变状态之间的可逆转换进行的,这反过来又调节了野生型AT2的动力学。最后,我们发现持续的核因子κB (NF-κB)激活如何将肿瘤发生与再生区分开来,使突变细胞破坏分化,有利于肿瘤生长。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cell stem cell
Cell stem cell 生物-细胞生物学
CiteScore
37.10
自引率
2.50%
发文量
151
审稿时长
42 days
期刊介绍: Cell Stem Cell is a comprehensive journal covering the entire spectrum of stem cell biology. It encompasses various topics, including embryonic stem cells, pluripotency, germline stem cells, tissue-specific stem cells, differentiation, epigenetics, genomics, cancer stem cells, stem cell niches, disease models, nuclear transfer technology, bioengineering, drug discovery, in vivo imaging, therapeutic applications, regenerative medicine, clinical insights, research policies, ethical considerations, and technical innovations. The journal welcomes studies from any model system providing insights into stem cell biology, with a focus on human stem cells. It publishes research reports of significant importance, along with review and analysis articles covering diverse aspects of stem cell research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信